Conflict of interest: Nothing to declare.
Hematopoietic cell transplantation with autologous cord blood in patients with severe aplastic anemia: An opportunity to revisit the controversy regarding cord blood banking for private use†
Article first published online: 2 MAR 2011
Copyright © 2011 Wiley-Liss, Inc.
Pediatric Blood & Cancer
Volume 56, Issue 7, pages 1009–1012, 1 July 2011
How to Cite
Rosenthal, J., Woolfrey, A. E., Pawlowska, A., Thomas, S. H., Appelbaum, F. and Forman, S. (2011), Hematopoietic cell transplantation with autologous cord blood in patients with severe aplastic anemia: An opportunity to revisit the controversy regarding cord blood banking for private use. Pediatr. Blood Cancer, 56: 1009–1012. doi: 10.1002/pbc.22970
- Issue published online: 12 APR 2011
- Article first published online: 2 MAR 2011
- Manuscript Accepted: 16 NOV 2010
- Manuscript Received: 6 AUG 2010
- autologous transplant;
- cord blood;
- severe aplastic anemia (SAA)
The controversy surrounding private banking of umbilical cord blood units (CBU), as a safeguard against future malignancy or other life-threatening conditions, raises many questions in pediatric clinical practice. Recent favorable experiences with autologous transplantation for severe aplastic anemia using privately stored CBU, suggested a possible utility. While private banking is difficult to justify statistically or empirically, there may exist rare cases where autologous transplant of stored umbilical CBU could be beneficial. The reality of privately banked CBU and the possibility for future discovery of additional indications for autologous cord blood transplant, motivated us to re-examine our attitudes towards private cord blood banking. Pediatr Blood Cancer 2011;56:1009–1012. © 2011 Wiley-Liss, Inc.